TuHURA Biosciences, Inc./NV (Nasdaq: HURA), an SEC filer in Pharmaceutical Preparations, closed at $2.11, -0.9%, on 2026-08-28, with a market cap of $136M as of 2026-08-27 and a return on equity of -169.2%. Institutional ownership, earnings history, filed financials and clinical trials are on the tabs below.
| # | Holder | Shares | Value | % of shares out | Δ QoQ |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 2,450,2562.5M | $4M | 3.85% | ADD 56% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 2,074,2282.1M | $4M | 3.26% | NEW† |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 986,922986,922 | $2M | 1.55% | ADD 49% |
| 4 | AQR CAPITAL MANAGEMENT LLC | 607,168607,168 | $1M | 0.95% | ADD 3580% |
| 5 | STATE STREET CORP | 512,913512,913 | $918,114 | 0.81% | ADD 77% |
| 6 | NORTHERN TRUST CORP | 298,187298,187 | $533,754 | 0.47% | ADD 56% |
| 7 | VANGUARD FIDUCIARY TRUST CO | 287,133287,133 | $513,968 | 0.45% | NEW |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 253,641253,641 | $454,017 | 0.40% | NEW |
| 9 | Bank of New York Mellon Corp | 211,568211,568 | $378,708 | 0.33% | — |
| 10 | Apollon Wealth Management, LLC | 158,010158,010 | $282,838 | 0.25% | ADD 18% |
† NEW this big is usually a rename.
Ranked by each filer’s own reported value, not shares.
1 holder — The filer reported no value for this line, so it carries no dollar figure and is left out of the percentage and value columns.
| Biggest buyers | Δ shares | Δ value | |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | +2,074,228 | $4M | OPEN |
| BlackRock, Inc. | +883,892 | $2M | ADD |
| AQR CAPITAL MANAGEMENT LLC | +590,670 | $1M | ADD |
| GEODE CAPITAL MANAGEMENT, LLC | +324,441 | $580,749 | ADD |
| VANGUARD FIDUCIARY TRUST CO | +287,133 | $513,968 | OPEN |
| Biggest sellers | Δ shares | Δ value | |
|---|---|---|---|
| VANGUARD GROUP INC | −2,319,762 | $4M | CLOSE |
| MORGAN STANLEY | −152,364 | $272,732 | TRIM |
| BARCLAYS PLC | −43,374 | $77,639 | TRIM |
| Hurlow Wealth Management Group, Inc. | −31,444 | $56,285 | CLOSE |
| WELLS FARGO & COMPANY/MN | −20,764 | $37,168 | TRIM |
Prior quarter split-rebased · 13Fs are long, US-listed only.
| Holder | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 391K | 374K | 1.3M | 1.5M | 1.6M | 2.5M | $4M |
| VANGUARD CAPITAL MANAGEMENT LLC | — | — | — | — | — | 2.1M | $4M |
| GEODE CAPITAL MANAGEMENT, LLC | 265K | 276K | 583K | 623K | 662K | 987K | $2M |
| AQR CAPITAL MANAGEMENT LLC | — | — | — | 34K | 16K | 607K | $1M |
| STATE STREET CORP | 23K | 31K | 228K | 276K | 289K | 513K | $918,114 |
| NORTHERN TRUST CORP | 57K | 57K | 201K | 187K | 192K | 298K | $533,754 |
| VANGUARD FIDUCIARY TRUST CO | — | — | — | — | — | 287K | $513,968 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | — | — | — | — | — | 254K | $454,017 |
| Bank of New York Mellon Corp | — | — | 252K | 197K | 210K | 212K | $378,708 |
| Apollon Wealth Management, LLC | 62K | 115K | 115K | 134K | 134K | 158K | $282,838 |
Green = added, red = trimmed, grey = held; a dash is a quarter with no 13F on file — a gap, not an exit.
Breaks = no 13F that quarter.
Short interest has its own tab now — open SI →
SEC Form 13F · ~10,250 filers, 10y · long-only, US-listed, filed ≤45d after quarter-end.
“Item 4 of the Original Schedule 13D is hereby amended and supplemented to add the following: As described in Item 5, as a result of the issuance by the Issuer of additional shares of Common Stock, and not as a result of any acquisition or disposition of securities by the Reporting Person, the Reporting Person ceased to be the beneficial owner of more than five percent of the outstanding Common Stock on August 18, 2026. Accordingly, this Amendment constitutes the final amendment to the Schedule 1”
SEC Schedule 13D/G XML · group aggregate.
